Open Access

Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)

  • Authors:
    • Yusuke Matoba
    • Iori Kisu
    • Asako Sera
    • Megumi Yanokura
    • Kouji Banno
    • Daisuke Aoki
  • View Affiliations

  • Published online on: January 4, 2019     https://doi.org/10.3892/br.2019.1182
  • Pages: 79-86
  • Copyright: © Matoba et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Though assisted reproduction technology has been developed, a treatment for absolute uterine factor infertility (AUFI), such as defects in the uterus, has not yet been established. Regenerative medicine has been developed and applied clinically over recent years; however, whole solid organs still cannot be produced. Though uterine regeneration has the potential to be a treatment for AUFI, there have been only a few studies on uterine regeneration involving the myometrium in vivo. In the present report, those relevant articles are reviewed. A literature search was conducted in PubMed with a combination of key words, and 10 articles were found, including nine in rat models and one in a mouse model. Of these studies, eight used scaffolds and two were performed without scaffolds. In four of these studies, scaffolds were re‑cellularized with various cells. In the remaining four studies, scaffolds were transplanted alone, or other structures were used. Though the methods differed, the injured uterus recovered well, morphologically and functionally, in every study. Only 10 articles were relevant to our investigation, but the results were favorable, if limited to partial regeneration. Recently, uterus transplantation (UTx) has been investigated as a treatment for AUFI. However, UTx has many problems in the medical, ethical and social fields. Though the artificial uterus was also researched and some improvements in this technology were reported, it will take long time for this to reach a clinically applicable stage. Though the results of uterine regeneration studies were promising, these studies were conducted using animal models, so further human studies and trials are needed.
View References

Related Articles

Journal Cover

February-2019
Volume 10 Issue 2

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Matoba Y, Kisu I, Sera A, Yanokura M, Banno K and Aoki D: Current status of uterine regenerative medicine for absolute uterine factor infertility (Review). Biomed Rep 10: 79-86, 2019.
APA
Matoba, Y., Kisu, I., Sera, A., Yanokura, M., Banno, K., & Aoki, D. (2019). Current status of uterine regenerative medicine for absolute uterine factor infertility (Review). Biomedical Reports, 10, 79-86. https://doi.org/10.3892/br.2019.1182
MLA
Matoba, Y., Kisu, I., Sera, A., Yanokura, M., Banno, K., Aoki, D."Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)". Biomedical Reports 10.2 (2019): 79-86.
Chicago
Matoba, Y., Kisu, I., Sera, A., Yanokura, M., Banno, K., Aoki, D."Current status of uterine regenerative medicine for absolute uterine factor infertility (Review)". Biomedical Reports 10, no. 2 (2019): 79-86. https://doi.org/10.3892/br.2019.1182